TradeTech Group’s liquidity provider, CFH Clearing, announced on Monday that it has integrated PrimeXM’s XCore technology in London (LD4) and Tokyo (TY3). This means that CFH Clearing can now provide local liquidity to brokers and clients in London and Tokyo.
The addition of XCore, an engine that provides a centralized environment for liquidity and risk management, means that CFH Clearing can offer its clients easier access to its liquidity in both data centers. This development is part of a larger partnership with the financial technology provider, PrimeXM which began in 2009.
Leading the way in Asia
Since PrimeXM and CHF Clearing began its partnership, PrimeXM has significantly expanded its presence in Asia. According to the statement, the region is one of the company’s strategic areas of focus over the past few years. As a result, the implementation of XCore has strengthened CFH’s leadership position in Asia.
HotForex extends partnership with Paris Saint-GermainGo to article >>
Speaking to Finance Magnates Matthew Maloney, the CEO of CFH Clearing said: “Our Asia growth is broad based, we are pleased to see customer development and growth from numerous countries. Asia remains a key focus for our growth ambitions and we are pleased to serve leading clients across the region, and welcome a dialogue with anyone looking to receive our award-winning offering.”
Commenting on the development, Marc Levin, Chief Commercial Officer at CFH Clearing, said: “This integration means that our Asia coverage is now unparalleled. Being able to offer liquidity in both TY3 and LD4 is a significant differentiator for CFH, and our superior execution capabilities in TY3 will reinforce our position as a leading liquidity provider in Asia.
“We have made a major investment in the PrimeXM partnership, which has already been a huge success and integrating with XCore in TY3 and LD4 was a natural development of this existing relationship. We believe having PrimeXM as a technology partner for our liquidity offer will be the catalyst for significant growth for CFH in the future.”